Document is current
Any future updates will be listed below
-
Authors
Shi, Beili
Akbari, Pedram
Pourafkari, Marina
Iliuta, Ioan-Andrei
Guiard, Elsa
Quist, Crystal F.
Song, Xuewen
Hillier, David
Khalili, Korosh https://orcid.org/0000-0002-3496-8744
Pei, York
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research Strategy for Patient Oriented Research (SPOR) program grant in Chronic Kidney Disease (CAN-Solve-CKD; Y.P.).
- License Information
-
More Information
Article History
Received: 26 March 2019
Accepted: 9 July 2019
First Online: 29 July 2019
Competing Interests
: Y.P. had received compensation for participating in advisory board with Otsuka and Sanofi/Genzyme pharmaceuticals. There are no additional competing interests or disclosures.
